Literature DB >> 2127307

Abnormal serine hydroxymethyl transferase activity in the temporal lobes of schizophrenics.

R Waziri1, S Baruah, T S Hegwood, A D Sherman.   

Abstract

We studied the kinetics of the enzyme serine hydroxymethyl transferase (SHMT) and the concentration of its metabolic substrates serine and glycine, in the postmortem brains of controls and schizophrenics. The Km of SHMT, and the concentration of serine and glycine were all significantly higher in the temporal lobes of brain tissues from schizophrenics than in those from controls. These differences were not observed in the frontal lobe specimens. Neuroleptics, age, sex and autolysis time did not contribute to these differences. The role of SHMT deficiency in schizophrenia is discussed in relation to the production of glycine and 1-carbon units from which purines and thereby adenosine is produced. Both glycine and adenosine are potent neuromodulatory substances for the release of dopamine and glutamate, neurotransmitters which have been implicated in the pathophysiology of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2127307     DOI: 10.1016/0304-3940(90)90048-e

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  MicroRNAs suggest a new mechanism for altered brain gene expression in schizophrenia.

Authors:  Joseph T Coyle
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-26       Impact factor: 11.205

2.  Glycine, serine, and leucine metabolism in different regions of rat central nervous system.

Authors:  I dos Santos Fagundes; L N Rotta; I D Schweigert; S C Valle; K R de Oliveira; A Huth Krüger; K B Souza; D O Souza; M L Perr
Journal:  Neurochem Res       Date:  2001-03       Impact factor: 3.996

3.  Characterization of the formate (for) locus, which encodes the cytosolic serine hydroxymethyltransferase of Neurospora crassa.

Authors:  C R McClung; C R Davis; K M Page; S A Denome
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

Review 4.  Allosteric modulators for the treatment of schizophrenia: targeting glutamatergic networks.

Authors:  Frank S Menniti; Craig W Lindsley; P Jeffrey Conn; Jayvardhan Pandit; Panayiotis Zagouras; Robert A Volkmann
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

5.  Haploinsufficiency of cytosolic serine hydroxymethyltransferase in the Smith-Magenis syndrome.

Authors:  S H Elsea; R C Juyal; S Jiralerspong; B M Finucane; M Pandolfo; F Greenberg; A Baldini; P Stover; P I Patel
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025

6.  Glycine transport inhibitors for the treatment of schizophrenia.

Authors:  Kenji Hashimoto
Journal:  Open Med Chem J       Date:  2010-05-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.